Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Daiichi Sankyo
Boehringer Ingelheim
Moodys
Citi
Teva
Cerilliant
Argus Health
Fish and Richardson
Baxter

Generated: February 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020802

« Back to Dashboard

NDA 020802 describes EXCEDRIN (MIGRAINE), which is a drug marketed by Glaxosmithkline Cons and is included in one NDA. It is available from four suppliers. Additional details are available on the EXCEDRIN (MIGRAINE) profile page.

The generic ingredient in EXCEDRIN (MIGRAINE) is acetaminophen; aspirin; caffeine. There are sixty-six drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the acetaminophen; aspirin; caffeine profile page.
Summary for 020802
Tradename:EXCEDRIN (MIGRAINE)
Applicant:Glaxosmithkline Cons
Ingredient:acetaminophen; aspirin; caffeine
Patents:0
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 020802
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
EXCEDRIN (MIGRAINE) acetaminophen; aspirin; caffeine TABLET;ORAL 020802 NDA GlaxoSmithKline Consumer Healthcare Holdings (US) LLC 0067-2035 N 0067-2035-20
EXCEDRIN (MIGRAINE) acetaminophen; aspirin; caffeine TABLET;ORAL 020802 NDA GlaxoSmithKline Consumer Healthcare Holdings (US) LLC 0067-2035 N 0067-2035-91

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:TABLET;ORALStrength250MG;250MG;65MG
Approval Date:Jan 14, 1998TE:RLD:Yes

Expired US Patents for NDA 020802

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline Cons EXCEDRIN (MIGRAINE) acetaminophen; aspirin; caffeine TABLET;ORAL 020802-001 Jan 14, 1998 ➤ Try a Free Trial ➤ Try a Free Trial
Glaxosmithkline Cons EXCEDRIN (MIGRAINE) acetaminophen; aspirin; caffeine TABLET;ORAL 020802-001 Jan 14, 1998 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Daiichi Sankyo
Teva
Covington
Farmers Insurance
Deloitte
US Department of Justice
Moodys
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot